EU Lags Behind US In Device Cybersecurity Guidance, But Harmonization On Horizon
This article was originally published in Clinica
Executive Summary
The US FDA appears to be ahead of the EU in the effort to issue guidelines specific to medical device cybersecurity. But experts say regulators in the EU are likely to eventually harmonize as part of a global effort to address cybersecurity risks.
You may also be interested in...
Is Enough Being Done About Cybersecurity In The EU? Contradictory Views Raise Regulatory Questions
A recent report from the UK Royal Academy of Engineering suggests that more efforts are needed to ensure cybersecurity protections for medical devices. But a key European industry trade association says that cybersecurity is adequately addressed from a regulatory standpoint in the EU.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.